Table of Content

1 Therapeutic Vaccines Market Introduction and Overview
1.1 Therapeutic Vaccines Definition
1.2 Market Size Analysis by Types
1.3 Market Size Analysis by Application
1.4 Research Purposes
1.5 Report Timeline
1.6 Economic Analysis of Global Regions
1.7 Inflation Analysis
1.8 The Impact of the Russian-Ukrainian War on the Market
2 Market Competition by Manufacturers
2.1 Global Therapeutic Vaccines Revenue and Market Share by Manufacturer
2.2 Manufacturers Therapeutic Vaccines Production Sites, Area Served, Product Types
2.3 Therapeutic Vaccines Market Competitive Situation and Trends
2.3.1 Therapeutic Vaccines Market Concentration Rate
2.3.2 Global Top 5 and Top 10 Players Market Share by Revenue in 2024
2.3.3 Mergers & Acquisitions, Expansion
3 Players Profiles
3.1 Valeant Pharmaceuticals
3.1.1 Valeant Pharmaceuticals Company Profile
3.1.2 Therapeutic Vaccines Product Overview
3.1.3 Valeant Pharmaceuticals Therapeutic Vaccines Market Performance (2019-2024)
3.1.4 Valeant Pharmaceuticals Business Overview
3.2 BioVex Inc
3.2.1 BioVex Inc Company Profile
3.2.2 Therapeutic Vaccines Product Overview
3.2.3 BioVex Inc Therapeutic Vaccines Market Performance (2019-2024)
3.2.4 BioVex Inc Business Overview
3.3 Inovio Pharmaceuticals Inc
3.3.1 Inovio Pharmaceuticals Inc Company Profile
3.3.2 Therapeutic Vaccines Product Overview
3.3.3 Inovio Pharmaceuticals Inc Therapeutic Vaccines Market Performance (2019-2024)
3.3.4 Inovio Pharmaceuticals Inc Business Overview
3.4 Immunocellular Therapeutics Ltd
3.4.1 Immunocellular Therapeutics Ltd Company Profile
3.4.2 Therapeutic Vaccines Product Overview
3.4.3 Immunocellular Therapeutics Ltd Therapeutic Vaccines Market Performance (2019-2024)
3.4.4 Immunocellular Therapeutics Ltd Business Overview
3.5 Agenus Inc
3.5.1 Agenus Inc Company Profile
3.5.2 Therapeutic Vaccines Product Overview
3.5.3 Agenus Inc Therapeutic Vaccines Market Performance (2019-2024)
3.5.4 Agenus Inc Business Overview
3.6 GlaxoSmithKline plc
3.6.1 GlaxoSmithKline plc Company Profile
3.6.2 Therapeutic Vaccines Product Overview
3.6.3 GlaxoSmithKline plc Therapeutic Vaccines Market Performance (2019-2024)
3.6.4 GlaxoSmithKline plc Business Overview
3.7 Pfizer Inc.
3.7.1 Pfizer Inc. Company Profile
3.7.2 Therapeutic Vaccines Product Overview
3.7.3 Pfizer Inc. Therapeutic Vaccines Market Performance (2019-2024)
3.7.4 Pfizer Inc. Business Overview
3.8 Novartis AG
3.8.1 Novartis AG Company Profile
3.8.2 Therapeutic Vaccines Product Overview
3.8.3 Novartis AG Therapeutic Vaccines Market Performance (2019-2024)
3.8.4 Novartis AG Business Overview
3.9 Argos Therapeutics
3.9.1 Argos Therapeutics Company Profile
3.9.2 Therapeutic Vaccines Product Overview
3.9.3 Argos Therapeutics Therapeutic Vaccines Market Performance (2019-2024)
3.9.4 Argos Therapeutics Business Overview
3.10 Bavarian Nordic
3.10.1 Bavarian Nordic Company Profile
3.10.2 Therapeutic Vaccines Product Overview
3.10.3 Bavarian Nordic Therapeutic Vaccines Market Performance (2019-2024)
3.10.4 Bavarian Nordic Business Overview
3.11 Transgene
3.11.1 Transgene Company Profile
3.11.2 Therapeutic Vaccines Product Overview
3.11.3 Transgene Therapeutic Vaccines Market Performance (2019-2024)
3.11.4 Transgene Business Overview
3.12 Galena Biopharma and Vaccinogen Inc
3.12.1 Galena Biopharma and Vaccinogen Inc Company Profile
3.12.2 Therapeutic Vaccines Product Overview
3.12.3 Galena Biopharma and Vaccinogen Inc Therapeutic Vaccines Market Performance (2019-2024)
3.12.4 Galena Biopharma and Vaccinogen Inc Business Overview
4 Global Therapeutic Vaccines Historical and Forecast Market Analysis by Type
4.1 Global Therapeutic Vaccines Revenue and Market Share by Type
4.2 Global Therapeutic Vaccines Revenue Market Forecast by Type (2024-2030)
5 Global Therapeutic Vaccines Historical and Forecast Market Analysis by Application
5.1 Global Therapeutic Vaccines Revenue Market Share by Application (2019-2024)
5.2 Therapeutic Vaccines Revenue Market Forecast by Application (2024-2030)
6 Global Market Growth Trends Analysis
6.1 Global Therapeutic Vaccines Market Size & Forecast (2019-2030)
6.2 Therapeutic Vaccines Growth Trends Analysis by Regions
6.2.1 Therapeutic Vaccines Market Size by Regions: 2019 VS 2024 VS 2030
6.2.2 Therapeutic Vaccines Historic Revenue Market Size by Regions (2019-2024)
6.2.3 Therapeutic Vaccines Forecasted Revenue Market Size by Regions (2024-2030)
6.2.4 North America Therapeutic Vaccines Market Size & Forecast (2019-2030)
6.2.5 Europe Therapeutic Vaccines Market Size & Forecast (2019-2030)
6.2.6 China Therapeutic Vaccines Market Size & Forecast (2019-2030)
6.2.7 Japan Therapeutic Vaccines Market Size & Forecast (2019-2030)
6.2.8 Korea Therapeutic Vaccines Market Size & Forecast (2019-2030)
6.2.9 Southeast Asia Therapeutic Vaccines Market Size & Forecast (2019-2030)
6.2.10 India Therapeutic Vaccines Market Size & Forecast (2019-2030)
6.2.11 South America Therapeutic Vaccines Market Size & Forecast (2019-2030)
6.2.12 Middle East & Africa Therapeutic Vaccines Market Size & Forecast (2019-2030)
7 North America
7.1 North America Therapeutic Vaccines Revenue by Players
7.2 North America Therapeutic Vaccines Revenue by Types
7.3 North America Therapeutic Vaccines Revenue by Applications
7.4 North America Therapeutic Vaccines Revenue, Gross and Gross Margin (2019-2024)
7.5 North America PEST Analysis
8 Europe
8.1 Europe Therapeutic Vaccines Revenue by Players
8.2 Europe Therapeutic Vaccines Revenue by Types
8.3 Europe Therapeutic Vaccines Revenue by Applications
8.4 Europe Therapeutic Vaccines Revenue, Gross and Gross Margin (2019-2024)
8.5 Europe PEST Analysis
9 China
9.1 China Therapeutic Vaccines Revenue by Players
9.2 China Therapeutic Vaccines Revenue by Types
9.3 China Therapeutic Vaccines Revenue by Applications
9.4 China Therapeutic Vaccines Revenue, Gross and Gross Margin (2019-2024)
9.5 China PEST Analysis
10 Japan
10.1 Japan Therapeutic Vaccines Revenue by Players
10.2 Japan Therapeutic Vaccines Revenue by Types
10.3 Japan Therapeutic Vaccines Revenue by Applications
10.4 Japan Therapeutic Vaccines Revenue, Gross and Gross Margin (2019-2024)
10.5 Japan PEST Analysis
11 Korea
11.1 Korea Therapeutic Vaccines Revenue by Players
11.2 Korea Therapeutic Vaccines Revenue by Types
11.3 Korea Therapeutic Vaccines Revenue by Applications
11.4 Korea Therapeutic Vaccines Revenue, Gross and Gross Margin (2019-2024)
11.5 Korea PEST Analysis
12 Southeast Asia
12.1 Southeast Asia Therapeutic Vaccines Revenue by Players
12.2 Southeast Asia Therapeutic Vaccines Revenue by Types
12.3 Southeast Asia Therapeutic Vaccines Revenue by Applications
12.4 Southeast Asia Therapeutic Vaccines Revenue, Gross and Gross Margin (2019-2024)
12.5 Southeast Asia PEST Analysis
13 India
13.1 India Therapeutic Vaccines Revenue by Players
13.2 India Therapeutic Vaccines Revenue by Types
13.3 India Therapeutic Vaccines Revenue by Applications
13.4 India Therapeutic Vaccines Revenue, Gross and Gross Margin (2019-2024)
13.5 India PEST Analysis
14 South America
14.1 South America Therapeutic Vaccines Revenue by Players
14.2 South America Therapeutic Vaccines Revenue by Types
14.3 South America Therapeutic Vaccines Revenue by Applications
14.4 South America Therapeutic Vaccines Revenue, Gross and Gross Margin (2019-2024)
14.5 South America PEST Analysis
15 Middle East & Africa
15.1 Middle East & Africa Therapeutic Vaccines Revenue by Players
15.2 Middle East & Africa Therapeutic Vaccines Revenue by Types
15.3 Middle East & Africa Therapeutic Vaccines Revenue by Applications
15.4 Middle East & Africa Therapeutic Vaccines Revenue, Gross and Gross Margin (2019-2024)
15.5 Middle East & Africa PEST Analysis
16 Therapeutic Vaccines Business Cost Analysis
16.1 Proportion of Business Cost Structure
16.1.1 Labor Cost
16.1.2 Operating Expenses
16.2 Therapeutic Vaccines Industrial Chain Analysis
17 Therapeutic Vaccines Industry Dynamic Analysis
17.1 Therapeutic Vaccines Market Trends Analysis
17.2 Therapeutic Vaccines Market Drivers Analysis
17.3 Therapeutic Vaccines Market Challenges Analysis
17.4 Therapeutic Vaccines Market Restraints Analysis
18 Research Findings and Conclusion